摘要
CD20阴性弥漫性大B细胞淋巴瘤(DLBCL)是一类罕见的侵袭性较强且较难诊断的淋巴增生性疾病,多发于免疫抑制合并病毒感染者。该文报道了1例原发于淋巴结的70岁CD20阴性DLBCL女性患者,其反复发热约半年,左侧颈部淋巴结进行性肿大,质韧,无触痛。首诊考虑为转移性肿瘤,最终由专业的病理医师对颈部淋巴结活组织切片进行复检,行免疫组织化学检查示P63(+++),CD30(+++),LCA(+++),PAX8(+++),P53(90%+),PAX5(+++),MUM1(+),BCL2(+++),BCL6(+++),C-MYC(80%+),Ki-67 (index 30%);分子病理示EBER(散在+),CD20(-),TIA1(-),CD43 (-),EMA (-),CD7 (-),ALK (-),Ber-EP4 (-),CD3 (-),CDX2(-),CK20(-),CK7(-),Napsin A(-),TTF-1(-),WT-1(-),CD10(-),考虑为CD20阴性DLBCL(间变亚型,非生发中心型)。结合影像学、血液学等辅助检查确诊为DLBCL。确诊后予患者CTOD方案(环磷酰胺+地塞米松+吡柔比星)化学治疗,其病情稳定后出院,随后失访。
CD20-negative diffuse large B-cell lymphoma (DLBCL) is a rare and invasive type of lymphoproliferative disease, which is difficult to be diagnosed and primarily occurs in patients with immunosuppression complicated with viral infection. In this study, one female 70-year-old patient diagnosed with CD20- negative DLBCL originating from the lymph nodes was reported. She experienced recurrent fever for approximately half a year, and progressive enlargement in the left cervical lymph nodes with toughening and no tenderness. The patient was suspected with a metastatic tumor during the first diagnosis, and finally diagnosed with lymphoma via biopsy of the cervival lymph nodes by professional pathologists, hnmunohistochemical examination demonstrated P63 (+++), CD30 (+++), LCA (+++), PAX8 (+++), P53 (90% +), PAX5 (+++), MUM1 (+), BCL2 (+++), BCL6 (+++), C-MYC (80% +) and Ki-67 (index 30%). The molecular pathological examination revealed EBER (diffuse + ), CD20 (-), TIA1 (-), CD43 (-), EMA (-), CD7 (-), ALK (-), Ber-EP4 (-), CD3 (-), CDX2 (-), CK20 (-), CK7 (-), NapsinA (-), TTF-1 (-), WT-1 (-) and CD10 (-). The possibility of negative CD20 DLBCL was considered (anaplastic, non-germinal center B-cell-like). The diagnosis of DLBCL was confirmed combined with auxiliary examinations, such as imaging and hematological tests. She received chemotherapy using the CTOD regimen ( cyclophosphamide + dexamethasone + pirobisin) and was discharged after her physcial condition became stable. She was lost to subsequent follow-up.
作者
王樱姿
Wang Yingzi(Department of Ultrasonic Medicine,the Third Affiliated Hospital of Guangzhou Medical University,Guangzhou 510180,China)
出处
《新医学》
2018年第10期762-764,共3页
Journal of New Medicine